The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSUBX.L Regulatory News (SUBX)

  • There is currently no data for SUBX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Outcome of the Board Meeting February 01,2021

2 Feb 2021 12:38

RNS Number : 7409N
Subex Limited
02 February 2021
 

February 02, 2021

 

To

The London Stock Exchange

10 Paternoster Square

London

EC4M 7LS

 

Dear Sir/Madam,

 

Sub: Subex Limited "The Company"- Outcome of the Board Meeting held on February 01, 2021.

 

Please be informed that the agenda items summarized hereunder were discussed and approved at the Board Meeting held on February 01, 2021 at Bengaluru:

 

Financial Results:

 

1. The Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine-months ended December 31, 2020.

 

Others Matters:

 

2. Declaration of interim dividend of Rs. 0.5/- (10 %) per equity share of par value of Rs.5/- each for the financial year 2020-21. Further, pursuant to Regulation 42 of SEBI (Listing Obligations and Disclosure Requirements), 2015 "SEBI (LODR) Regulations, 2015", the Company has fixed February 11, 2021 as Record Date for determining the eligibility of the shareholders for Interim Dividend. The Interim Dividend will be paid on or before March 02, 2021.

 

3. Change in the terms of appointment of Mr. Shiva Shankar Naga Roddam, (DIN: 07212118), Whole-Time Director & COO of the Company, with effect from February 01, 2021.

 

4. Re-classification of the below persons belonging to the 'Promoter/Promoter Group' category, to the 'Public' Category. The approval of the Board towards reclassification is subject to the approval of the members of the Company and the other regulatory authorities, if any, in terms of Regulation 31A of SEBI (LODR) Regulations, 2015 and amendments thereof.

 

 

Sl. No.

Names of the Promoter/Promoter Group

No. of shares held

1.

Mr. Subash Menon-Promoter

 

 

NIL

2.

Mr. Sudeesh Yezhuvath- Promoter Group

3.

Kivar Holdings Private Limited- Promoter Group

 

5. Appointment of V. Sreedharan & Associates, Company Secretaries, for conducting the Secretarial Audit for the financial year 2020-21.

 

6. Appointment of RSM Astute Consulting Pvt. Ltd as Internal Auditors of the Company for the financial year ending March 31, 2022.

 

7. Grant of 12,40,500 Stock options by the Nomination & Remuneration Committee of the Board of Directors, in accordance with ESOP 2018 Scheme of the Company.

 

Please find enclosed:

 

a) The Unaudited Consolidated Financial Results of the Company for the quarter and nine months ended December 31, 2020.

 

We request you to take the aforesaid notification on record.

 

 

Yours truly,

For Subex Limited

 

Vinod Kumar Padmanabhan

Managing Director & CEO

DIN:06563872

 

 

 

 

 

 

 

 

 

 

 

SUBEX LIMITED

Registered office: Pritech Park - SEZ, Block-09, 4th Floor, B Wing, Survey No. 51-64/4, Outer ring road, Bellandur, Bangalore -560 103

Statement of Unaudited Consolidated Financial Results for the quarter and nine months ended December 31, 2020

( in Lakhs)

 

 

Quarter ended

Year to date figures for the nine months ended

Year ended

 

Particulars

December 31, 2020

September 30, 2020

December 31, 2019

December 31, 2020

December 31, 2019

March 31, 2020

 

 

Unaudited

Unaudited

Unaudited

Unaudited

Unaudited

Audited

 

Income

 

 

 

 

 

 

1

Revenue from operations

9,388

9,329

9,609

27,587

26,071

36,498

2

Other income

106

100

52

302

228

563

3

Total income (1+2)

9,494

9,429

9,661

27,889

26,299

37,061

 

Expenses

 

 

 

 

 

 

 

Employee benefits expense (Refer note 4)

5,256

4,890

4,556

14,703

13,302

17,454

 

Finance costs

38

103

115

251

358

477

 

Depreciation and amortization expense

424

365

367

1,155

1,116

1,508

 

Exchange fluctuation loss/(gain), net

449

438

512

698

(39)

(887)

 

Other expenses

1,648

1,461

2,768

4,651

7,216

10,513

4

Total expenses

7,815

7,257

8,318

21,458

21,953

29,065

 

 

 

 

 

 

 

 

5

Profit before exceptional items and tax (3-4)

1,679

2,172

1,343

6,431

4,346

7,996

 

Exceptional items

Impairment of goodwill [Refer note 5(i)] Provision no longer required written back Provision for claim settlement [Refer note 5(ii)] Provision for service taxreceivable (Refer note6

Gain on termination of lease agreement (Refer note 7)

 

-

 

-

 

(31,473)

 

-

 

(31,473)

 

(31,473)

 

-

-

761

-

761

761

 

-

-

(1,054)

-

(1,054)

(1,054)

 

-

(267)

-

(267)

-

-

 

-

554

-

554

-

-

6

Total exceptional items

-

287

(31,766)

287

(31,766)

(31,766)

 

 

 

 

 

 

 

 

7

Net profit/ (loss) before tax (5-6)

1,679

2,459

(30,423)

6,718

(27,420)

(23,770)

8

Tax expense, net

Current tax charge

Provision for MAT credit [Refer note 8 (i)]

Provision - foreign withholding taxes [Refer note 8 (ii)] Deferred tax charge (Refer note 9)

 

 

 

 

 

 

 

49

7

80

57

82

117

 

-

-

-

-

-

425

 

208

386

163

940

647

754

 

551

841

606

2,109

1,964

1,849

 

Total tax expense

808

1,234

849

3,106

2,693

3,145

 

 

 

 

 

 

 

 

9

Net profit/ (loss) for the period/ year (7-8)

871

1,225

(31,272)

3,612

(30,113)

(26,915)

10

Other comprehensive income/ (loss) net of tax expense

Items that will be reclassified subsequently to profit or loss:

Net exchange differences gain on translation of foreign operations

 

Items that will not be reclassified subsequently to profit or loss:

Re-measurement loss on defined benefits plan

 

 

 

 

 

 

 

455

158

595

575

205

5

 

 

(14)

 

(20)

 

(20)

 

(38)

 

(55)

 

(34)

 

Total other comprehensive income/ (loss)

441

138

575

537

150

(29)

 

 

 

 

 

 

 

 

11

Total comprehensive income/ (loss) for the period/ year (9+10)

1,312

1,363

(30,697)

4,149

(29,963)

(26,944)

12

 

 

13

Paid up equity share capital (Refer note 10)

[face value of ₹ 5 each w.e.f September 29, 2020 and ₹ 10 upto September 28,

2020]

Other equity

28,100

 

 

-

28,100

 

 

-

56,200

 

 

-

28,100

 

 

-

56,200

 

 

-

56,200

 

 

(4,661)

14

Earnings/(loss) per share (of ₹ 5/- each w.e.f September 29, 2020 and ₹ 10 upto September 28, 2020) (not annualised in case of the interim periods) (Refer note 10):

 

 

 

 

 

 

 

- Basic

- Diluted

0.16

0.16

0.23

0.23

(5.77)

(5.77)

0.67

0.66

(5.51)

(5.51)

(4.94)

(4.94)

 

 

 

 

1

Notes:

The above results have been reviewed by the Audit Committee and approved by the Board of Directors in their meeting held on February 01, 2021.

The financial results have been prepared in accordance with the recognition and measurement principles laid down in the applicable Indian Accounting Standards ("Ind AS") prescribed under section 133 of the Companies Act, 2013, read with relevant rules thereunder and in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended.

The financial results of Subex Limited (Standalone information):

( in Lakhs)

2

3

 

 

Quarter ended

Year to date figures for the nine months ended

Year ended

 

Particulars

December 31, 2020

September 30, 2020

December 31, 2019

December 31, 2020

December 31, 2019

March 31, 2020

 

 

Unaudited

Unaudited

Unaudited

Unaudited

Unaudited

Audited

 

Total income

510

1,095

289

2,937

731

3,170

 

Net profit/ (loss) before tax

125

440

(21,913)

1,465

(22,687)

(20,470)

 

Net profit/ (loss) for the period/ year

129

436

(21,913)

1,465

(22,687)

(20,588)

 

Total comprehensive income / (loss) for the period/ year

127

434

(21,915)

1,460

(22,961)

(20,609)

4

Employee benefits expenses for the quarters ended December 31, 2020, September 30, 2020, and December 31, 2019 are net of reversal of provision no longer required, in respect of employee incentives relating to sales and delivery commissions, amounting to 43 Lakhs, 62 Lakhs and 149 Lakhs, respectively, and that for the nine months ended December 31, 2020 and December 31, 2019 amounting to 333 Lakhs and ₹ 450 Lakhs, respectively and for that year ended March 31, 2020 amounting to ₹ 692 lakhs.

5

(i) During the previous year ended March 31, 2020, considering the challenges and significant investment requirements of telecom operators which has resulted in longer opportunity conversion cycle and lower spends towards IT solutions, the management had carried out the annual impairment exercise as at December 31, 2019 in respect of carrying value of goodwill and basis valuation carried out by an external valuation expert, had made an impairment provision of ₹ 31,473 Lakhs towards carrying value of goodwill. In view of the COVID -19 pandemic, the management has reassessed its projections and assumptions and has concluded that, the carrying value of it's goodwill as at December 31, 2020 is appropriate.

 

 

 

(ii) During the previous year ended March 31, 2020, the Company had entered into settlement agreement with former MD & CEO and former COO of the company in respect of long drawn litigation wherein certain claims were made against the Company. In terms of the settlement agreement, the Company has paid an amount of 820 lakhs (net of 234 Lakhs recoverable from such ex-employees). Accordingly, the aforesaid litigation is amicably settled.

 

6

During the previous quarter ended September 30, 2020, service tax receivable of ₹ 267 lakhs has been provided for considering the uncertainty as regards to its realisation.

7

Represents gain arising on termination of the lease agreement of existing office premises in India, accounted in accordance with Ind AS 116 - Leases.

8

(i) During the previous year ended March 31, 2020, the MAT credit entitlement of ₹ 425 Lakhs has been provided considering the uncertainty with regards to its utilisation.

 

(ii) Represents provision in respect of withholding taxes deducted/ deductible by the overseas customers of the Group.

9

Deferred tax charge, comprises of liability arising on account of tax benefits from amortisation of intangible assets of Subex Assurance LLP, net of deferred tax assets arising on account of carry forward losses and other taxable temporary differences, which arose mainly on account of business restructuring effected from November 1, 2017, wherein, the Company's RMS business and the Digital business was transferred on going concern basis to Subex Assurance LLP and Subex Digital LLP respectively.

 

10

The Board of Directors in its meeting held on February 07, 2020, approved a scheme of Capital Reduction in accordance with Section 52 of the Companies Act, 2013 and Section 66 of the Companies Act, 2013 read with National Company Law Tribunal ('NCLT') (Procedure for reduction of share capital of Company) Rules, 2016 and other applicable provisions of the Companies Act, 2013. The Hon'ble NCLT approved the said Scheme vide its order dated September 23, 2020. Consequently, the Company filed a certified copy of the Order with Registrar of Companies ('ROC') on September 29, 2020 and utilized an amount of ₹ 28,100 Lakhs from paid -up share capital of the Company by reducing the face value of the equity shares from ₹ 10/- to ₹ 5/- each and ₹ 10,301 Lakhs from securities premium to write-off its accumulated losses of ₹ 38,401 Lakhs.

 

 

11

The Group is engaged in the business of software products and related services, which are monitored as a single segment by the Chief Operating Decision Maker, accordingly, these, in the context of Ind AS 108 on Operating Segments Reporting are considered to constitute one segment and hence the Group has not made any additional segment disclosures.

 

 

12

The full impact of COVID - 19 still remains uncertain and could be different from the estimates considered while preparing these consolidated financial results. The Group shall continue to closely monitor any material changes to future economic conditions.

 

 

13

The Code on Social Security, 2020 ('Code') relating to employee benefits during employment and post-employment benefits received Presidential assent in September 2020. The Code has been published in the Gazette of India. However, the date on which the Code will come into effect has not been notified and the final rules/interpretation have not yet been issued. The Group will assess the impact of the Code when it comes into effect and will record any related impact in the period the Code becomes effective.

 

14

The Board of Directors at its meeting held on February 01,2021 has declared an interim dividend of ₹ 0.50/- (10 %) per equity share on face value of ₹ 5/- each for the financial year 2020-2021.

 

Place: Bengaluru

Date: February 01, 2021

 

 

 

 

For further details on the results, please visit our website: www.subex.com

 

Vinod Kumar Padmanabhan Managing Director & CEO

 

         

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ROMUPUQWPUPGGPP
Date   Source Headline
9th Aug 202210:35 amRNSOutcome of the Board Meeting held on August 8,2022
30th Jun 20223:42 pmRNSProposed termination of GDRs & De-listing
1st Jun 202211:52 amRNSOutcome of Board Meeting dated May 30, 2022
1st Feb 202211:11 amRNSOutcome of Board Meeting held on Jan 31, 2022
29th Oct 20218:37 amRNSOutcome of Board Meeting held on October 28, 2021
10th Aug 202111:41 amRNSOutcome of the Board Meeting on August 09, 2021
15th Jun 202111:56 amRNSNotice of Twenty Seventh Annual General Meeting
18th May 202111:20 amRNSOutcome of the Board Meeting held on May 17, 2021
2nd Feb 202112:38 pmRNSOutcome of the Board Meeting February 01,2021
10th Nov 202011:32 amRNSOutcome of the Board Meeting November 09,2020
1st Sep 202012:01 pmRNSNotice of the Twenty Sixth Annual General Meeting
11th Aug 20202:34 pmRNSOutcome of Board Meeting on August 10, 2020
12th May 20207:31 amRNSSubex Limited-Outcome of Board Meeting 11 May 2020
12th Feb 20207:00 amRNSOutcome of the Board Meeting of Subex Limited
11th Nov 201910:17 amRNSResults for quarter & half year ended Sep 30, 2019
13th Aug 201911:02 amRNSOutcome of the Board Meeting - August 12, 2019
10th Jun 201911:55 amRNSNotice of the Twenty Fifth Annual General Meeting
14th May 20199:51 amRNSSubex Limited Outcome -Board Meeting -May 13, 2019
30th Jan 20197:00 amRNSOutcome of the Board Meeting held on Jan 29, 2019
2nd Nov 20187:08 amRNSOutcome of the Board Meeting- October 31, 2018
1st Aug 20187:00 amRNS1st Quarter Results
12th Jul 20187:26 amRNSThe Twenty Fourth AGM of Subex Limited
27th Jun 20187:38 amRNSSubex Limited-Outcome -Board Meeting June 26,2018
4th May 20183:00 pmRNSFinal Results
22nd Mar 201811:29 amRNSAppointment of MD & CEO of Subex Ltd
30th Jan 20189:50 amRNSFinancial Results - 3rd Quarter
13th Nov 201710:01 amRNSOutcome of Board Meeting held on November 10 2017
2nd Nov 201711:54 amRNSRestructuring of the Business wef Nov 1, 2017
5th Oct 20177:00 amRNSOutcome of Board Meeting held on October 4, 2017
22nd Aug 201711:47 amRNSOutcome of Board Meeting held on August 21, 2017
31st Jul 201711:38 amRNS1st Quarter Results
10th Jul 201711:40 amRNSRedemption of FCCB III
4th Jul 201711:05 amRNSNotice of AGM
5th Jun 201711:25 amRNSOutcome of the Board Meeting held on June 05, 2017
5th Jun 201711:15 amRNSOutcome of the Board Meeting held on June 05, 2017
26th May 20177:00 amRNSFinal Results
24th Mar 201711:41 amRNSOutcome of the Board Meeting held on March 24 2017
7th Mar 20178:26 amRNSIntimation on Redemption of FCCBs
3rd Feb 201710:46 amRNSSubex Limited 3rd Quarter Results
7th Dec 20167:50 amRNSOutcome of Board Meeting held on December 06 2016
14th Sep 20167:47 amRNS1st Quarter Results
22nd Aug 201611:14 amRNSNotice of AGM
10th Aug 201610:43 amRNSOutcome of the Board Meeting- August 9, 2016
25th May 201610:51 amRNSSubex Limited-Outcome of Board Meeting
11th Feb 201612:18 pmRNS3rd Quarter Results
3rd Nov 20152:44 pmRNSResult of Meeting
27th Aug 20158:45 amRNSSubex Limited (The Company)-Update
13th Aug 20152:00 pmRNS1st Quarter Results
3rd Jul 201511:55 amRNSNotice of the Outcome of Bondholders meeting
27th May 201512:44 pmRNSNotice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.